SG11202112592YA - Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine - Google Patents

Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine

Info

Publication number
SG11202112592YA
SG11202112592YA SG11202112592YA SG11202112592YA SG11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA SG 11202112592Y A SG11202112592Y A SG 11202112592YA
Authority
SG
Singapore
Prior art keywords
olopatadine
mometasone
treatment
combination
allergic rhinitis
Prior art date
Application number
SG11202112592YA
Other languages
English (en)
Inventor
Neelima Khairatkar-Joshi
Abhay Kulkarni
Dinesh Pradeep Wale
Vikram M Bhosale
Piyush Agarwal
Patrick Keohane
Sudeesh K Tantry
Chad Oh
Original Assignee
Glenmark Specialty Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/903,597 external-priority patent/US10758550B2/en
Application filed by Glenmark Specialty Sa filed Critical Glenmark Specialty Sa
Publication of SG11202112592YA publication Critical patent/SG11202112592YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202112592YA 2018-02-23 2019-02-22 Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine SG11202112592YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/903,597 US10758550B2 (en) 2013-10-04 2018-02-23 Treatment of allergic rhinitis using a combination of mometasone and olopatadine
PCT/IB2019/051465 WO2019162902A1 (en) 2018-02-23 2019-02-22 Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine

Publications (1)

Publication Number Publication Date
SG11202112592YA true SG11202112592YA (en) 2021-12-30

Family

ID=65818565

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112592YA SG11202112592YA (en) 2018-02-23 2019-02-22 Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine

Country Status (13)

Country Link
EP (1) EP3755375A1 (ja)
JP (1) JP7391026B2 (ja)
KR (1) KR20200125625A (ja)
CN (1) CN111787954B (ja)
AU (1) AU2019224850A1 (ja)
BR (1) BR112020016817A2 (ja)
CA (1) CA3088490A1 (ja)
CO (1) CO2020010335A2 (ja)
EA (1) EA202091744A1 (ja)
MX (1) MX2020008741A (ja)
PH (1) PH12020551311A1 (ja)
SG (1) SG11202112592YA (ja)
WO (1) WO2019162902A1 (ja)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US6127353A (en) 1991-09-06 2000-10-03 Schering Corporation Mometasone furoate monohydrate, process for making same and pharmaceutical compositions
PE44995A1 (es) 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
AU2003291497B2 (en) * 2002-11-12 2007-12-20 Alcon, Inc. The use of an anti-allergy agent and a steroid to treat allergic rhinitis
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
PT2173169E (pt) * 2007-06-28 2014-09-03 Cydex Pharmaceuticals Inc Entrega nasal de soluções de corticosteróide aquosas
US8642069B2 (en) 2008-08-27 2014-02-04 Alexander D. Goldin Composition and method for treating colds
CN104173273A (zh) 2009-07-17 2014-12-03 爱尔康研究有限公司 儿童用奥洛他定鼻腔喷雾方案
CN102078326A (zh) * 2009-11-26 2011-06-01 天津金耀集团有限公司 含有聚维酮碘与糠酸莫米松的局部使用组合物
CN102078285A (zh) * 2009-11-26 2011-06-01 天津金耀集团有限公司 含有皮质激素和h1受体拮抗剂的鼻用原位凝胶
WO2011141929A2 (en) 2010-05-11 2011-11-17 Cadila Healthcare Limited Aqueous pharmaceutical compositions of fluticasone and olopatadine
US9370483B2 (en) * 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10646500B2 (en) 2013-10-04 2020-05-12 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine

Also Published As

Publication number Publication date
CA3088490A1 (en) 2019-08-29
JP2021514947A (ja) 2021-06-17
CN111787954A (zh) 2020-10-16
AU2019224850A1 (en) 2020-08-13
KR20200125625A (ko) 2020-11-04
RU2020126691A (ru) 2022-03-23
WO2019162902A1 (en) 2019-08-29
EA202091744A1 (ru) 2021-01-15
CN111787954B (zh) 2023-09-05
JP7391026B2 (ja) 2023-12-04
EP3755375A1 (en) 2020-12-30
MX2020008741A (es) 2020-09-28
BR112020016817A2 (pt) 2020-12-15
PH12020551311A1 (en) 2021-09-06
RU2020126691A3 (ja) 2022-03-23
CO2020010335A2 (es) 2020-11-10

Similar Documents

Publication Publication Date Title
IL263985A (en) Medical device for the treatment of sinuses and/or ears and methods of using the device
IL276494A (en) Niraprib formulations for children and methods for treating children
EP3878348C0 (en) MEDICAL DEVICES AND METHODS OF USE
EP3554401A4 (en) EYE TREATMENT DEVICES AND ASSOCIATED PROCEDURES FOR USE
IL264301A (en) Treatment of Fabry disease in ert-naive and ert-experienced patients
IL281445A (en) Therapeutic nanoparticles and methods for their use
HK1215674A1 (zh) 結合使用莫米松和奧洛他定治療過敏性鼻炎
IL254791B (en) Medical device for an artery and methods of use
EP3863511A4 (en) BODY-WEARABLE MEDICAL DEVICE WITH DISPOSABLE AND REUSABLE COMPONENTS
IL288310A (en) Modulators of cot and methods of using them
SG11202000423XA (en) Treatment of fabry disease in ert-naïve and ert-experienced patients
IL281824A (en) Non-invasive portable device and method to assess mental conditions
ZA201902873B (en) Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients
GB201600263D0 (en) Fixation device and method of manufacture and use
GB2604264B (en) Medical treatment device and method of operation thereof
IL280859A (en) Use of gboxdol for the treatment of gastrointestinal disorders and asthma
EP4003137C0 (fr) Surtube et dispositif médical utilisant ce surtube
SG11202112592YA (en) Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine
PL3628356T3 (pl) Instrument medyczny i urządzenie wytwarzające
IL284689A (en) Endoscopic device and methods of its use
GB2605918B (en) Configuring a medical device and patient treatment
IL280691A (en) A device for massaging and stretching certain body parts
EP3867386A4 (en) BRASSICA EVENT MON94100 AND METHOD OF USING THEM
GB2574747B (en) Use of lambda interferons in the treatment of obesity-related disorders and related diseases
HUE063390T2 (hu) Szövetzáró eszköz és orvosi mûszer